Covidien - world's fifth largest healthcare products company - begins trading
This article was originally published in Clinica
Executive Summary
Covidien, the former healthcare division of the $41bn conglomerate Tyco International, made its debut as an independent company on the New York Stock Exchange and in Bermuda on Monday (July 2). The move comes nearly a year after Tyco International first revealed it was considering splitting up into three separate and more manageable businesses.